Actively hiring
Vaccines
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$100k
1 round on record
Latest round
$100k
Venture round · Apr 2026 · 6 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Apr 2026 | $100k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | PROXAG CORP | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Melvin PullenExecutive Officer, DirectorSEC Form D
James SullivanExecutive Officer, DirectorSEC Form D
Overview
Proxag develops patented agricultural adjuvants, biostimulants, soil conditioning technologies and formulation innovations that improve crop performance, spray efficacy and agricultural productivity worldwide.
People

Melvin Pullen
Executive Officer, Director

James Sullivan
Executive Officer, Director

Anneke Pullen
Director

Erroll Pullen
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Tampa
United States
HQ
PROXAG™
10-50 est. staff
P.O. Box 173101, Tampa FL 33672 USA
Financials
Total raised
$100k
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $100k | Details |
